Version vom 18. August 2022, 18:37 Uhr
coviki.org was constructed in may 2020 at less than 10.000 published papers by pubmed accessibility. it was possible to keep up with human-bassed assortment of papers into subject topics. 2021 is at 62k papers at june 9th and 2020...
I will show here the most remarkable appearing papers as I got noticed at initally screening the pubmed readouts.
preTAGGED urgent papers 2022 August
|
2021 Jan-Jun
2020 intersting papers
anything to be included but not shifted into topics yet
0801
35702735 2022. Building a reverse dictionary with specific application to the COVID-19 pandemic.
35643308 2022. SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing.
|
35654561 2022. REMOVED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.
35682757 2022. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
35743031 2022. Human Superantibodies to 3CL(pro) Inhibit Replication of SARS-CoV-2 across Variants.
35711011 2022. Emergency myelopoiesis in critical illness: lessons from the COVID-19 pandemic.
35634577 2022. Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection.
35756895 2022. Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.
35675509 2022. Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers.
35695891 2022. A close shave: How SARS-CoV-2 induces the loss of cilia.
35674692 2022. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity.
35676568 2022. Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia.
35683485 2022. The Role of Heparin in COVID-19: An Update after Two Years of Pandemics.
35743491 2022. Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients.
|
35708626 2022. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
35768681 2022. Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans.
|
35712857 2022. Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies.
|
35700866 2022. Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
35639922 2022. A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients.
35658098 2022. Deep Denoising of Raw Biomedical Knowledge Graph From COVID-19 Literature, LitCovid, and Pubtator: Framework Development and Validation.
|
35662463 2022. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning.
35747583 2022. Myopia: Mechanisms and Strategies to Slow Down Its Progression.
35720802 2022. Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso.
35653049 2022. Metformin therapy in COVID-19: inhibition of NETosis.
|
35663631 2022. Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
35763298 2022. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
35730564 2022. Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections.
35709336 2022. Combating COVID-19 Using Generative Adversarial Networks and Artificial Intelligence for Medical Images: Scoping Review.
35702397 2022. Immunologic Responses Following COVID-19 Vaccination in Patients with Membranous Nephropathy Receiving Anti-CD38 Felzartamab Therapy: Results from the Phase 1b/2a M-PLACE Study.
35637695 2022. Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection.
35713613 2022. Culturing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Diagnosis and Genome Sequencing.
35643099 2022. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
|
35752184 2022. 2 years of the Access to COVID-19 Tools-Accelerator.
|
35636438 2022. Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients.
35714658 2022. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
35743886 2022. COVID-19 on Chest CT: Translating Known Microscopic Findings to Imaging Observations.
|
35757386 2022. A Theory of Frustration and Its Effect.
35730280 2022. A complex network model for a society with socioeconomic classes.